Pharma News

The day in pharma, read in minutes.

Updated Aug 06, 2026

Latest news

11 stories
NewsNew

Tarsus Pharmaceuticals Acquires Alkeus Pharmaceuticals to Advance Stargardt Disease Oral Therapy

Tarsus acquires Alkeus, adding Phase 3 gildeuretinol for Stargardt disease and triggering GMP scale-up and NDA strategy work.

Vaibhavi M.Aug 06, 2026Read more
Tarsus Pharmaceuticals Acquires Alkeus Pharmaceuticals to Advance Stargardt Disease Oral Therapy
NewsNew

Allergan Aesthetics Files sNDA for BOTOX Cosmetic Jawline Indication with FDA

Allergan Aesthetics files sNDA with FDA to expand BOTOX Cosmetic labeling to include a jawline contouring indication.

Vaibhavi M.Aug 06, 2026Read more
Allergan Aesthetics Files sNDA for BOTOX Cosmetic Jawline Indication with FDA
News

Lexicon Pharmaceuticals Nears NDA Resubmission for ZYNQUISTA in Type 1 Diabetes Following FDA-Defined Safety Threshold

Lexicon's ZYNQUISTA NDA resubmission nears completion as STENO1 safety data approach FDA-defined thresholds; Q4 2026 filing targeted.

Vaibhavi M.Aug 06, 2026Read more
Lexicon Pharmaceuticals Nears NDA Resubmission for ZYNQUISTA in Type 1 Diabetes Following FDA-Defined Safety Threshold
News

Ascendis Pharma Achieves Week 78 COACH Milestone as YUVIWEL Tops 170 U.S. Enrollments

Ascendis Pharma completes reACHin Trial enrollment for infant achondroplasia while COACH Week 78 data and YUVIWEL uptake signal expanding regulatory and manufacturing scope.

Vaibhavi M.Aug 06, 2026Read more
Ascendis Pharma Achieves Week 78 COACH Milestone as YUVIWEL Tops 170 U.S. Enrollments
News

Propanc Biopharma Achieves Over 90% Tumor Growth Inhibition for PRP in PDAC Preclinical Models

Propanc Biopharma reports >90% tumor growth inhibition for PRP in PDAC models, with GMP production and a Phase 1b CTA filing targeted for late 2026.

Vaibhavi M.Aug 06, 2026Read more
Propanc Biopharma Achieves Over 90% Tumor Growth Inhibition for PRP in PDAC Preclinical Models
News

FDA Signals Enforcement Shift on Unapproved Desiccated Thyroid Extract Products Used by 1.5 Million Patients

FDA notifies DTE manufacturers of forthcoming compliance and development guidance, raising NDA submission urgency for 1.5 million-patient market.

Pharma Now Editorial TeamAug 06, 2026Read more
FDA Signals Enforcement Shift on Unapproved Desiccated Thyroid Extract Products Used by 1.5 Million Patients
News

3PBIOVIAN Achieves GMP Manufacturing Milestone in PITÁGORAS Personalized TCR Therapy Program

3PBIOVIAN establishes GMP manufacturing protocols for AI-identified TCR candidates within the €1.6M PITÁGORAS personalized immunotherapy consortium.

Vaibhavi M.Aug 06, 2026Read more
3PBIOVIAN Achieves GMP Manufacturing Milestone in PITÁGORAS Personalized TCR Therapy Program
News

Sight Sciences Receives FDA Clearance For OMNI Ultra Surgical System To Treat Glaucoma

Sight Sciences receives FDA clearance for its OMNI Ultra Surgical System, an implant-free MIGS device for treating open-angle glaucoma.

Simantini Singh DeoAug 06, 2026Read more
Sight Sciences Receives FDA Clearance For OMNI Ultra Surgical System To Treat Glaucoma
News

Editas Medicine Appoints Dr. Patrick Ellinor To Board Of Directors

Editas Medicine appoints cardiovascular genetics expert Dr. Patrick Ellinor to its Board as it advances its gene editing pipeline including EDIT-401.

Simantini Singh DeoAug 06, 2026Read more
Editas Medicine Appoints Dr. Patrick Ellinor To Board Of Directors
News

IQVIA And Medera Partner To Advance Cardiac Gene Therapy And Human-Based Drug Discovery

IQVIA partners with Medera to accelerate cardiac gene therapy development and human-based drug discovery through Sardocor and Novoheart.

Simantini Singh DeoAug 06, 2026Read more
IQVIA And Medera Partner To Advance Cardiac Gene Therapy And Human-Based Drug Discovery
News

Applied Biologics Begins AATB Reaccreditation Process To Maintain High Tissue Banking Standards

Applied Biologics begins its AATB reaccreditation process, marking nearly a decade of continuous tissue banking accreditation for XWRAP.

Simantini Singh DeoAug 06, 2026Read more
Applied Biologics Begins AATB Reaccreditation Process To Maintain High Tissue Banking Standards